Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Analysts Call Trump's New Drug Deals Symbolic
Regulatory & Compliance Analysts Call Trump's New Drug Deals Symbolic

Today, we're speaking with James Maitland, an expert in healthcare innovation and the intricate dynamics between the pharmaceutical industry, government policy, and financial markets. We'll be exploring the recent wave of drug pricing deals between major pharmaceutical companies and the White

Which Mental Health App Is Right for You in 2025?
Digital Health Which Mental Health App Is Right for You in 2025?

The digital landscape of mental well-being has undergone a profound transformation, evolving far beyond simple timers and relaxation sounds into sophisticated, science-backed platforms designed to provide meaningful support. These applications have matured into robust tools that leverage

Report Highlights Key Strategies to Prevent Medication Errors
Patient Care Report Highlights Key Strategies to Prevent Medication Errors

The complex environment of modern healthcare, while offering advanced treatments, also presents numerous opportunities for error, with medication administration being one of the most critical and vulnerable processes. A single misplaced vial, an ambiguous label, or a misunderstood verbal order can

Feds Charge Done Global in $100M Adderall Scheme
Digital Health Feds Charge Done Global in $100M Adderall Scheme

The rapid expansion of telehealth has been widely celebrated for its potential to democratize healthcare access, but a recent federal indictment has cast a harsh light on the industry's darker side, particularly concerning the prescription of controlled substances. Federal prosecutors have unsealed

FDA Faces Deep Divide on AI Medical Device Regulation
Regulatory & Compliance FDA Faces Deep Divide on AI Medical Device Regulation

The U.S. Food and Drug Administration (FDA) finds itself navigating a complex and fractured landscape as it endeavors to craft a regulatory framework for the real-world performance of medical devices driven by artificial intelligence (AI) and machine learning (ML). Following a call for public

Medicare to Retroactively Pay Shutdown Telehealth Claims
Digital Health Medicare to Retroactively Pay Shutdown Telehealth Claims

The recent federal government shutdown in October 2025 sent shockwaves through many sectors, but few felt the impact as acutely as healthcare providers and the millions of seniors who rely on Medicare. Amid the administrative chaos, critical telehealth service authorizations expired, plunging

Lawmakers Doubt VA's Risky Health Record System Relaunch
Digital Health Lawmakers Doubt VA's Risky Health Record System Relaunch

Amidst intense scrutiny and a history marred by critical failures, the Department of Veterans Affairs is facing a formidable challenge from lawmakers who demand nothing short of a "flawless" execution for the planned relaunch of its new electronic health record (EHR) system. The ambitious and

House GOP Bill Targets Costs, Skips Subsidy Extension
Infrastructure & Management House GOP Bill Targets Costs, Skips Subsidy Extension

With a critical healthcare deadline rapidly approaching, House Republican leaders have introduced a comprehensive 111-page draft bill designed to tackle healthcare affordability through a series of market-based reforms. The legislation is being aggressively fast-tracked, with a Rules Committee

AHR Offers Investors Stability in Volatile Markets
Digital Health AHR Offers Investors Stability in Volatile Markets

In today's unpredictable financial landscape, where traditional equities face heightened volatility, astute investors are increasingly turning their attention toward alternative assets that promise both security and consistent returns. Amidst this shift, Real Estate Investment Trusts (REITs) have

Why Is the Betavoltaic Power Market Surging?
Infrastructure & Management Why Is the Betavoltaic Power Market Surging?

An extraordinary shift is underway in the world of specialized energy, where the global market for betavoltaic power is projected to more than double in value, rocketing from nearly USD 53 million in 2024 to over USD 131 million by 2032. This remarkable expansion, representing a compound annual

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later